Search bioRxiv⌕ Search

bioRxiv · 10.64898/2026.05.01.722213

Staphylococcus epidermidis Genomic Plasticity Modulates Horizontal Gene Transfer

Abstract

Horizontal gene transfer (HGT) is an important driver of evolution, enabling organisms to rapidly adapt to environmental stressors. In bacteria, anti-mobile genetic element (MGE) defense systems are believed to limit HGT, raising the question of how bacterial populations balance defense with the acquisition of genetic novelty. Most insights into anti-MGE defense come from heterologous experimental setups, where candidate systems are artificially expressed in a host and observed over only a few generations. Such approaches can obscure the long-term evolutionary and ecological dynamics of native anti-MGE systems. Here, we show that laboratory-evolved Staphylococcus epidermidis populations rapidly delete a large, flexible genomic region containing anti-MGE defense systems and other accessory genes. This process generates stable, heterogeneous populations composed of cells that either retain or lack these defenses. Loss of this region is associated with a marked increase in HGT. Notably, the balance between anti-MGE defense and HGT is strongly influenced by environmental conditions. In nutrient-rich liquid media, defense systems and adjacent accessory genes are frequently lost, whereas under stress, such as antibiotic exposure, these defenses are maintained, leading to reduced HGT rates. This genetic and phenotypic heterogeneity enhances adaptive potential by enabling the uptake of beneficial MGEs while preserving protection under adverse conditions. Overall, the rapid gain and loss of anti-MGE defense systems highlight how environmental factors, independent of MGEs themselves, can shape HGT dynamics.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tran, M., Hernandez Viera, A. J., Rosu, J. A., Tran, P., Goldman, D. A., Mo, C.. 2026-05-05. Staphylococcus epidermidis Genomic Plasticity Modulates Horizontal Gene Transfer. https://doi.org/10.64898/2026.05.01.722213

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

pTRIP, a novel integration plasmid for Listeria monocytogenes

In the past decades, several tools to genetically modify the human pathogen Listeria monocytogenes were developed. Here, we constructed a new integrative plasmid system for L. monocytogenes named pTRIP, for treB insertion plasmid. pTRIP is a vector which stably integrates into the treB locus of the wild type EGD-e. This locus encodes the sole trehalose-specific EIIB and EIIC component of a phosphotransferase system. Successful integration leads to the disruption of treB and thus, to an inability of the resulting L. monocytogenes strains to grow on trehalose as sole carbon source. Due to integration through double homologous recombination, it is the first integrative system which does not require antibiotic selection pressure. To assess functionality of the pTRIP system, prfA and its native promoter region were integrated into the treB locus of a {Delta}prfA strain. Complementation was confirmed in 78% of the isolated clones, indicating successful integration of prfA into the treB locus. We further constructed derivatives of pTRIP harboring the constitutive Pp60 (pTRIP1) and the inducible Prha (pTRIP2) promoter to further expand application possibilities. Microscopic analyses confirmed the functionality of both promoter constructs and showed dose-dependent induction for Prha. pTRIP is an efficient tool for stable gene expression as well as functional studies and expands genetic modification possibilities for L. monocytogenes.

microbiology↗

A rational design strategy and validation for protease-resistant fusion-inhibitor antiviral peptides

Peptide-based fusion inhibitors are promising pharmaceuticals in the fight against enveloped viruses relying on membrane fusion for host infection. However, peptide therapeutic applications have long been hindered by their poor stability in vivo. Here, we discovered that peptide inhibitors with the wildtype sequence of the heptad repeat 2 (HR2) domain of the SARS-CoV-2 spike protein are efficiently cleaved by Transmembrane Protease, Serine 2 (TMPRSS2), a key protease involved in the SARS-CoV-2 virus-cell fusion pathway. We then identified the corresponding cleavage sites and designed three protease-resistant peptides using ranking based on deep mutational scanning and natural occurrence. The three candidates all exhibit inhibitory activity in a cell-cell fusion assay. A high-resolution cryo-EM structure of the top candidate, HR2-NHN, bound to its HR1 target reveals the molecular basis for its potent activity. The top candidate of the cell-based screening assay significantly improved efficacy relative to the wildtype peptide when administered 12 h before infection in both an authentic virus-cell infection assay and a mouse assay. More broadly, our results suggest that the design strategies for protease-resistant peptides could be applied to a broad spectrum of other enveloped viruses and pave the way for the development of safe, prophylactic antivirals that can be administered before exposure.

microbiology↗

Host soluble inositol phosphate signaling promotes coronavirus replication

Coronaviruses rely extensively on host pathways for replication, making host-directed therapies an attractive strategy for broad-spectrum antivirals with reduced risk of viral resistance. Here we identify the host soluble inositol phosphate pathway as a previously unrecognized dependency for coronavirus infection. Genetic or pharmacologic inhibition of several kinases in this pathway markedly suppresses replication of both alpha- and betacoronaviruses, while increasing pathway activity promotes viral replication. We developed UNC7844, a potent multi-target inhibitor of these kinases, which reduces coronavirus replication by more than four orders of magnitude in cultured cells and suppresses coronavirus infection in mice. Mechanistically, UNC7844 suppresses inositol (pyro)phosphates production, disrupts phosphoinositide homeostasis, and impairs late endosomal dynamics, blocking early post-entry steps required for viral genome release and replication. Together, our findings establish the soluble inositol (pyro)phosphate pathway as an important regulator of coronavirus infection and highlight its inhibition as a promising host-directed antiviral strategy.

microbiology↗